Myricitrin Modulates NADPH Oxidase-Dependent ROS Production to Inhibit Endotoxin-Mediated Inflammation by Blocking the JAK-STAT1 and NOX2-p47phox PathwaysReport as inadecuate




Myricitrin Modulates NADPH Oxidase-Dependent ROS Production to Inhibit Endotoxin-Mediated Inflammation by Blocking the JAK-STAT1 and NOX2-p47phox Pathways - Download this document for free, or read online. Document in PDF available to download.

Oxidative Medicine and Cellular Longevity - Volume 2017 2017, Article ID 9738745, 20 pages - https:-doi.org-10.1155-2017-9738745

Research Article

Anhui Province Key Laboratory of Active Biological Macromolecules, Wannan Medical College, Wuhu, China

Department of Biochemistry, Wannan Medical College, Wuhu 241002, China

Department of Forensic Medicine, Wannan Medical College, Wuhu, China

Correspondence should be addressed to Yao Zhang

Received 10 October 2016; Revised 24 December 2016; Accepted 4 January 2017; Published 20 June 2017

Academic Editor: Ilaria Peluso

Copyright © 2017 Shimei Qi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Myricitrin, a naturally occurring polyphenol hydroxy flavonoid, has been reported to possess anti-inflammatory properties. However, the precise molecular mechanism of myricitrin’s effects on LPS-induced inflammation is unclear. In the present study, myricitrin significantly alleviated acute lung injury in mice. Myricitrin also markedly suppressed the production of NO, TNF-α, IL-6, and MCP-1 in RAW264.7 macrophage cells. The inhibition of NO was concomitant with a decrease in the protein and mRNA levels of iNOS. The phosphorylation of JAKs and STAT-1 was abrogated by myricitrin. Furthermore, myricitrin inhibited the nuclear transfer and DNA binding activity of STAT1. The JAK-specific inhibitor ruxolitinib simulated the anti-inflammatory effect of myricitrin. However, myricitrin had no impact on the MAPK signalling pathway. Myricitrin attenuated the generation of intracellular ROS by inhibiting the assembly of components of the gp91

and p47

. Suppression of ROS generation using NAC or apocynin or by silencing gp91

and p47

all demonstrated that decreasing the level of ROS inhibited the LPS-induced inflammatory response. Collectively, these results confirmed that myricitrin exhibited anti-inflammatory activity by blocking the activation of JAKs and the downstream transcription factor STAT1, which may result from the downregulation of NOX2-dependent ROS production mediated by myricitrin.





Author: Shimei Qi, Zunyong Feng, Qiang Li, Zhilin Qi, and Yao Zhang

Source: https://www.hindawi.com/



DOWNLOAD PDF




Related documents